News
A bunch of men have been talking about 'Ozempic penis' as a side-effect of the drug, but an expert has explained the truth ...
Novo Nordisk submits a higher 7.2 mg dose of Wegovy for EMA approval, backed by trials showing 21% weight loss in obesity and ...
Reduced monthly costs for uninsured patients still amount to around $500. That can put the drugs out of reach for many.
Investing.com -- Novo Nordisk (NYSE: NVO) stock rose 1% after the company announced it has submitted an application to the ...
Kate Farms has launched high-protein plant-based shakes to tackle "critical nutrition gaps" from GLP-1 use, its first product ...
3h
Investor's Business Daily on MSNRevived WeightWatchers Rallies, In 'Strongest Position In Years'Analyst initiates coverage of WeightWatchers with a buy rating after bankruptcy reemergence. IPO hot streak continues.
Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...
Researchers say GLP-1 medicines might be able to help with migraines.
A recent survey highlighted a widespread lack of understanding about the much-publicised GLP-1 weight-loss medications ...
A MUM-OF-TWO who shed almost half her bodyweight using fat jabs has shared the one piece of advice she wish she knew before ...
WeightWatchers has emerged from bankruptcy after slimming down its debts, as it pledged to combine weight-loss jabs with ...
There’s no doubt that GLP-1 drugs like Ozempic have been revolutionary — although the benefits do sometimes come with some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results